87 related articles for article (PubMed ID: 12777328)
1. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
Wakatsuki A; Okatani Y; Fukaya T
Circulation; 2003 May; 107(20):e197; author reply e197. PubMed ID: 12777328
[No Abstract] [Full Text] [Related]
2. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
Kaunitz AM
Circulation; 2003 Mar; 107(9):e67-8; author reply e67-8. PubMed ID: 12628963
[No Abstract] [Full Text] [Related]
3. Long-term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.
Sorensen MB; Collins P; Ong PJ; Webb CM; Hayward CS; Asbury EA; Gatehouse PD; Elkington AG; Yang GZ; Kubba A; Pennell DJ
Circulation; 2002 Sep; 106(13):1646-51. PubMed ID: 12270857
[TBL] [Abstract][Full Text] [Related]
4. Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.
Lizarelli PM; Martins WP; Vieira CS; Soares GM; Franceschini SA; Ferriani RA; Patta MC
Contraception; 2009 Jan; 79(1):35-40. PubMed ID: 19041439
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density and depot medroxyprogesterone acetate.
Albertazzi P; Bottazzi M; Steel SA
Contraception; 2006 Jun; 73(6):577-83. PubMed ID: 16730487
[TBL] [Abstract][Full Text] [Related]
6. [Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].
Zhou J; Lei ZW; Lü JQ; Sun J; Xu XW
Zhonghua Fu Chan Ke Za Zhi; 2005 Jan; 40(1):5-8. PubMed ID: 15774083
[TBL] [Abstract][Full Text] [Related]
7. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
[TBL] [Abstract][Full Text] [Related]
8. Decidual cast in a girl receiving depot medroxyprogesterone acetate--a case report.
Singh V; Talib N; Strickland J
J Pediatr Adolesc Gynecol; 2007 Jun; 20(3):191-4. PubMed ID: 17561189
[TBL] [Abstract][Full Text] [Related]
9. Urinary tract infection in the users of depot-medroxyprogesterone acetate.
Berger RE
J Urol; 2005 Sep; 174(3):941. PubMed ID: 16093999
[No Abstract] [Full Text] [Related]
10. Progestins initiate adverse events of menopausal estrogen therapy.
Thomas T; Rhodin J; Clark L; Garces A
Climacteric; 2003 Dec; 6(4):293-301. PubMed ID: 15011717
[TBL] [Abstract][Full Text] [Related]
11. Medroxyprogesterone acetate attenuates long-term effects of 17beta-estradiol in coronary arteries from hyperlipidemic rabbits.
Pedersen SH; Nielsen LB; Mortensen A; Sheykhzade M; Nilas L; Ottesen B
Steroids; 2006 Sep; 71(9):834-42. PubMed ID: 16815506
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.
Kaunitz AM; Darney PD; Ross D; Wolter KD; Speroff L
Contraception; 2009 Jul; 80(1):7-17. PubMed ID: 19501210
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic intracranial hypertension associated with depot medroxyprogesterone.
Chan JW
Eye (Lond); 2006 Dec; 20(12):1396-7. PubMed ID: 16440012
[No Abstract] [Full Text] [Related]
14. Same-day administration of depot-medroxyprogesterone acetate injection: a retrospective chart review.
Balkus J; Miller L
Contraception; 2005 May; 71(5):395-8. PubMed ID: 15854642
[TBL] [Abstract][Full Text] [Related]
15. Long-acting contraceptives in adolescents.
Tolaymat LL; Kaunitz AM
Curr Opin Obstet Gynecol; 2007 Oct; 19(5):453-60. PubMed ID: 17885461
[TBL] [Abstract][Full Text] [Related]
16. Urinary tract infection in the users of depot-medroxyprogesterone acetate.
Ziaei S; Ninavaei M; Faghihzadeh S
Acta Obstet Gynecol Scand; 2004 Oct; 83(10):909-11. PubMed ID: 15453884
[TBL] [Abstract][Full Text] [Related]
17. Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users.
Sereepapong W; Chotnopparatpattara P; Taneepanichskul S; Markham R; Russell P; Fraser IS
Hum Reprod; 2004 Mar; 19(3):547-52. PubMed ID: 14998949
[TBL] [Abstract][Full Text] [Related]
18. Effects of hormonal contraception on bone mineral density after 24 months of use.
Berenson AB; Breitkopf CR; Grady JJ; Rickert VI; Thomas A
Obstet Gynecol; 2004 May; 103(5 Pt 1):899-906. PubMed ID: 15121563
[TBL] [Abstract][Full Text] [Related]
19. [Methods for exploring arteries in humans: application to the study of estrogens].
Laurent S; Boutouyrie P
Therapie; 1999; 54(3):347-52. PubMed ID: 10500449
[TBL] [Abstract][Full Text] [Related]
20. Steroid receptor expression in vaginal epithelium of healthy fertile women and influences of hormonal contraceptive usage.
Ildgruben A; Sjöberg I; Hammarström ML; Bäckström T
Contraception; 2005 Nov; 72(5):383-92. PubMed ID: 16246667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
